Insider Transactions in Q1 2022 at 10x Genomics, Inc. (TXG)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 22
2022
|
Serge Saxonov Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,731
+5.7%
|
-
|
Mar 22
2022
|
Justin J. Mc Anear |
BUY
Grant, award, or other acquisition
|
Direct |
21,357
+26.29%
|
-
|
Mar 22
2022
|
Benjamin J. Hindson |
BUY
Grant, award, or other acquisition
|
Direct |
28,476
+13.11%
|
-
|
Feb 22
2022
|
Bradford Crutchfield Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
288
-0.29%
|
$22,464
$78.6 P/Share
|
Feb 22
2022
|
Justin J. Mc Anear |
SELL
Open market or private sale
|
Direct |
288
-0.74%
|
$22,464
$78.6 P/Share
|
Feb 22
2022
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
551
-0.06%
|
$42,978
$78.6 P/Share
|
Feb 22
2022
|
Benjamin J. Hindson |
SELL
Open market or private sale
|
Direct |
360
-0.22%
|
$28,080
$78.59 P/Share
|
Feb 15
2022
|
Bradford Crutchfield Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,000
-14.83%
|
$1,615,000
$95.13 P/Share
|
Feb 15
2022
|
Bradford Crutchfield Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,000
+12.91%
|
$17,000
$1.16 P/Share
|
Feb 08
2022
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,000
-0.33%
|
$1,068,000
$89.68 P/Share
|
Feb 08
2022
|
Serge Saxonov Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,038
+0.33%
|
$33,418
$11.48 P/Share
|
Jan 12
2022
|
Bradford Crutchfield Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,000
-1.75%
|
$2,057,000
$121.53 P/Share
|
Jan 12
2022
|
Bradford Crutchfield Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,000
+12.91%
|
$17,000
$1.16 P/Share
|
Jan 04
2022
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-0.23%
|
$2,130,000
$142.08 P/Share
|
Jan 04
2022
|
Serge Saxonov Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+0.32%
|
$33,407
$11.48 P/Share
|
Jan 03
2022
|
Benjamin J. Hindson |
SELL
Open market or private sale
|
Direct |
41,666
-3.7%
|
$6,083,236
$146.88 P/Share
|
Jan 03
2022
|
Benjamin J. Hindson |
BUY
Exercise of conversion of derivative security
|
Direct |
41,666
+8.81%
|
$1,791,638
$43.03 P/Share
|
Jan 03
2022
|
Justin J. Mc Anear |
SELL
Open market or private sale
|
Direct |
10,000
-4.43%
|
$1,470,000
$147.05 P/Share
|
Jan 03
2022
|
Justin J. Mc Anear |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+17.0%
|
$50,000
$5.04 P/Share
|